Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,092 | 14,200 | 17,439 | 56,843 | 26,470 |
| Marketable Securities | 37,188 | 13,607 | 26,407 | N/A | N/A |
| TOTAL | $52,115 | $29,090 | $44,956 | $57,564 | $27,208 |
| Non-Current Assets | |||||
| PPE Net | 1,954 | 2,919 | 2,256 | 2,584 | 864 |
| Intangibles | 2,042 | 2,672 | 2,874 | 2,952 | 987 |
| TOTAL | $3,996 | $5,591 | $5,130 | $5,536 | $1,850 |
| Total Assets | $56,111 | $34,681 | $50,086 | $63,100 | $29,059 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 365 | 657 | 1,157 | 1,176 | 582 |
| Accrued Expenses | 2,034 | 1,553 | 2,466 | 2,407 | 776 |
| TOTAL | $6,858 | $6,724 | $5,244 | $4,133 | $1,359 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,459 | 4,514 | 1,621 | 550 | N/A |
| TOTAL | $11,270 | $15,729 | $6,493 | $N/A | $N/A |
| Total Liabilities | $18,128 | $22,453 | $11,737 | $4,133 | $1,359 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,231 | 19,249 | 19,032 | 18,767 | N/A |
| Common Shares | 263 | 193 | 191 | 188 | 28 |
| Retained earnings | -123,330 | -104,807 | -76,467 | -46,584 | -23,099 |
| Other shareholders' equity | -306 | -1,383 | -2,631 | -5,134 | -9,511 |
| TOTAL | $37,983 | $12,228 | $38,349 | $58,967 | $27,700 |
| Total Liabilities And Equity | $56,111 | $34,681 | $50,086 | $63,100 | $29,059 |